Graham Strachan
Presidente en Ontario Mental Health Research Foundation .
Origen de la red de primer grado Graham Strachan.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
13
| Private Company | Pharmaceuticals: Major | 13 |
| Public Company | Biotechnology | 10 | |
Cita NeuroPharmaceuticals, Inc.
 Cita NeuroPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Allelix Biopharmaceuticals, Inc.
2
| Extinct | Pharmaceuticals: Major | 2 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Graham Strachan a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| NYMOX PHARMACEUTICAL CORPORATION | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| QUESTCOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Director of Finance/CFO | |
DNA Sciences, Inc.
 DNA Sciences, Inc. Medical SpecialtiesHealth Technology Part of AbbVie, Inc., DNA Sciences, Inc. is a company that develops and produces in vitro diagnostic and research reagent products. The company is based in Fremont, CA. The company was founded by Hugh Young Rienhoff. DNA Sciences was acquired by Genaissance Pharmaceuticals, Inc., part of AbbVie, Inc. from October 07, 2005 on April 01, 2003 for $1.30 million. | Medical Specialties | Director of Finance/CFO | |
| TELESTA THERAPEUTICS INC | Pharmaceuticals: Other | Chairman | |
| TYHEE GOLD CORP. | Precious Metals | Director/Board Member Director/Board Member | |
| TRILLIUM THERAPEUTICS | Biotechnology | Chief Executive Officer | |
| INNERGEX RENEWABLE ENERGY INC. | Electric Utilities | Director/Board Member | |
| AG GROWTH INTERNATIONAL INC. | Industrial Machinery | Chairman | |
Vive Crop Protection, Inc.
 Vive Crop Protection, Inc. Chemicals: AgriculturalProcess Industries Vive Crop Protection, Inc. develops crop protection products. The firm specializes in crop protection, delivery, agronomy, formulations chemistry, polymer chemistry, chemical engineering, industrial manufacturing development and patents. Its products include AZteroid, Bifender and Fenstro. The company was founded in 2006 and is headquartered in Toronto, Canada. | Chemicals: Agricultural | Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
Williams Creek Gold Ltd.
 Williams Creek Gold Ltd. Precious MetalsNon-Energy Minerals Williams Creek Gold Ltd. engages in the exploration of mineral properties. The company was founded on June 19, 1946 and is headquartered in Vancouver, Canada. | Precious Metals | Chairman Chief Executive Officer | |
Wilson Sonsini Goodrich & Rosati PC
 Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Wilson Sonsini Goodrich & Rosati PC provides legal services. Its services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Vaxis Therapeutics Corp
 Vaxis Therapeutics Corp Pharmaceuticals: MajorHealth Technology Part of DMK Pharmaceuticals Corp., Vaxis Therapeutics Corp manufactures and researches pharmaceutical products. The company is based in Kingston, Canada. Vaxis Therapeutics was acquired by Cellegy Pharmaceuticals, Inc. on November 29, 2001 for $4 million. | Pharmaceuticals: Major | Chief Executive Officer | |
| McGill University | College/University | Doctorate Degree Corporate Officer/Principal | |
| York University | College/University | Masters Business Admin Graduate Degree | |
BHP Coated Steel Corp
 BHP Coated Steel Corp SteelNon-Energy Minerals Part of Ternium SA, BHP Coated Steel Corp produces cold-rolled, metallic-coated and custom-painted steel coils for the construction and OEM markets. The company is based in Kalama, WA. BHP Coated Steel was acquired by IMSA Acero SA de CV on May 25, 2000 for $234 million. | Steel | Director of Finance/CFO | |
| San Diego State University | College/University | Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
| Elon University | College/University | Undergraduate Degree | |
| University of Toronto | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| The University of Waterloo | College/University | Undergraduate Degree Graduate Degree | |
| University of Maryland | College/University | Undergraduate Degree Doctorate Degree | |
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Biotechnology | Director/Board Member Chairman | |
Viron Therapeutics, Inc.
 Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
Birch Hill Equity Partners Management, Inc.
 Birch Hill Equity Partners Management, Inc. Investment ManagersFinance Birch Hill Equity Partners Management, Inc (Birch Hill Equity Partners) is a private equity firm founded in 1994 by Steve J Dent and John B MacIntyre. The firm is headquartered in Toronto, Canada. | Investment Managers | Private Equity Investor | |
Washington National Opera
 Washington National Opera Movies/EntertainmentConsumer Services Washington National Opera operates as an opera company. The company was founded in 1956 and is headquartered in Washington, DC. | Movies/Entertainment | President Director/Board Member | |
Wi2Wi, Inc.
 Wi2Wi, Inc. Specialty TelecommunicationsCommunications Wi2Wi, Inc. provides advanced microsystems, miniaturized embedded wireless connectivity solutions. Its products include wireless connectivity, timing and frequency control, and antennas and connectors. The company is headquartered in San Jose, CA. | Specialty Telecommunications | Director/Board Member Chairman | |
| Resolution Pharmaceuticals, Inc. | Chief Executive Officer | ||
| BIOX CORP | Chemicals: Specialty | Director/Board Member | |
| The Aliments Soyummi, Inc. | Director/Board Member Chairman | ||
PlantForm Corp.
 PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Ontario Genomics Institute (Private Equity)
 Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London. | Investment Managers | Corporate Officer/Principal | |
Ontario Bioscience Industry Organization
 Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services The Ontario Bioscience Industry Organization is a membership organization that engages in strategy, programming, policy development, and advocacy. The non-profit company is based in Toronto, Canada. The Canadian company was founded by Simon Goulet. Maura Campbell has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
| WI2WI CORPORATION | Telecommunications Equipment | Director/Board Member Chairman | |
| Lambert Family Trust | Director/Board Member | ||
| Remedies Health Care Services, Inc. | Founder | ||
Metamaterial Technologies, Inc.
 Metamaterial Technologies, Inc. SemiconductorsElectronic Technology Metamaterial Technologies, Inc. designs, develops and commercializes optical filters and metamaterial-based systems. It specializes in metamaterial research, nanofabrication, and computational electromagnetics. The company was founded by George Palikaras, Nadine Geddes, Themos Kallos and Paul McLaughlin in 2011 and is headquartered in Dartmouth, Canada. | Semiconductors | Director/Board Member | |
Investeco Capital Corp.
 Investeco Capital Corp. Investment ManagersFinance Investeco Capital Corp. (Investeco Capital) is an Independent Private Equity firm founded in 2002 by Michael de Pencier and Andrew Heintzman. The firm is headquartered in Toronto, CA. | Investment Managers | Private Equity Investor |
Estadísticas
Internacional
| Canadá | 33 |
| Estados Unidos | 16 |
| Bahamas | 2 |
| Reino Unido | 2 |
| Hong-Kong | 2 |
Sectorial
| Health Technology | 17 |
| Consumer Services | 10 |
| Finance | 6 |
| Commercial Services | 5 |
| Non-Energy Minerals | 4 |
Operativa
| Director/Board Member | 187 |
| Corporate Officer/Principal | 85 |
| Chairman | 51 |
| Independent Dir/Board Member | 48 |
| President | 34 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Paul Sekhri | 62 |
| Michael R. Sonnenreich | 31 |
| Charles Casamento | 27 |
| Hans P. Black | 26 |
| Mario Rosati | 24 |
| Timothy Morris | 21 |
| George Adams | 18 |
| Don B. Rix | 18 |
| Philippe Couillard | 17 |
| Bill Lambert | 15 |
| Michael Miller | 14 |
| Niclas Stiernholm | 13 |
| James Moodie Rae | 12 |
| Scott Robert Samuel | 12 |
| Perry B. Molinoff | 12 |
- Bolsa de valores
- Insiders
- Graham Strachan
- Conexiones Empresas
